About
Hunter Syndrome

Hunter syndrome is Mucopolysaccharidosis type II (MPS II). It takes its name from Charles Hunter(1873-1955) who first described two brothers with the disease in 1917.
MPS II is a rare X-linked lysosomal storage disorder caused by a deficiency of a specific enzyme, iduronate-2-sulfatase (IDS). In affected patients, glycosaminoglycan (GAG)
accumulates in the lysosomes of many organs and tissues contributing to the pathology associated with MPS II.